Taipei Exchange (TPEx) stock · 6620
Handa Pharma (6620): insider filings
In the last 12 months, company insiders filed 9 open-market buys.
- Insider buys / sales
- 9 / 012 months
- Insiders reporting
- 812 months
9 disclosed buys and sales on record since 15 October 2026. Directors, managers and holders of more than 10% report each month’s changes by the 15th of the next. Counts are shares bought and sold on the exchange, valued at the month-end close; stock dividends, gifts, inheritance, family transfers and declared plans are left out.
Latest disclosures
| Disclosed | Filed by | Type | Amount | Traded |
|---|---|---|---|---|
| 黃潤慈Company insider (Taiwan) | Buy | ≈ $16.4K | ||
| 陳曉柔Company insider (Taiwan) | Buy | ≈ $24.6K | ||
| 陳俊良Company insider (Taiwan) | Buy | ≈ $60.6K | ||
| 段宗一Company insider (Taiwan) | Buy | ≈ $57.3K | ||
| 楊啟余Company insider (Taiwan) | Buy | ≈ $32.8K | ||
| 張美芳Company insider (Taiwan) | Buy | ≈ $81.9K | ||
| 宋國峻Company insider (Taiwan) | Buy | ≈ $4.9K | ||
| 宋國峻Company insider (Taiwan) | Buy | ≈ $41K |